These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2909144)

  • 1. Differential effect of nicotine on plasma norepinephrine levels in normal humans and in patients with congestive heart failure.
    Goldsmith SR; Dodge-Brown D; Katz A; Crooks PA
    Am J Cardiol; 1989 Jan; 63(1):122-3. PubMed ID: 2909144
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.
    Levine TB; Francis GS; Goldsmith SR; Simon AB; Cohn JN
    Am J Cardiol; 1982 May; 49(7):1659-66. PubMed ID: 7044086
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure.
    Francis GS; Goldsmith SR; Ziesche SM; Cohn JN
    Am J Cardiol; 1982 Apr; 49(5):1152-6. PubMed ID: 7064841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers.
    Grassi G; Bolla G; Quarti-Trevano F; Arenare F; Brambilla G; Mancia G
    Eur J Heart Fail; 2008 Dec; 10(12):1186-91. PubMed ID: 18851926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion.
    Kramer RS; Mason DT; Braunwald E
    Circulation; 1968 Oct; 38(4):629-34. PubMed ID: 4300395
    [No Abstract]   [Full Text] [Related]  

  • 6. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness.
    Manthey J; Dietz R; Opherk D; Osterziel KJ; Leinberger H; Kübler W
    Am J Cardiol; 1992 Jul; 70(2):224-8. PubMed ID: 1626511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in norepinephrine levels in different vascular beds in congestive heart failure.
    Eichhorn EJ; Hatfield BA; Marcoux L
    Am J Cardiol; 1993 Feb; 71(5):442-6. PubMed ID: 8430636
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse consequences of high sympathetic nervous activity in the failing human heart.
    Kaye DM; Lefkovits J; Jennings GL; Bergin P; Broughton A; Esler MD
    J Am Coll Cardiol; 1995 Nov; 26(5):1257-63. PubMed ID: 7594040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure.
    Tygesen H; Rundqvist B; Waagstein F; Wennerblom B
    Am J Cardiol; 2001 Jun; 87(11):1308-11. PubMed ID: 11377364
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympathetic tone in congestive heart failure.
    Hasking GJ; Esler MD; Jennings GL
    Am J Cardiol; 1985 Nov; 56(13):912. PubMed ID: 4061334
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
    Al-Hesayen A; Parker JD
    Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sympatho-adrenergic function in the course of congestive heart failure. II. Circadian rhythm of urinary excretion of norepinephrine and epinephrine].
    Descovich GC; Bernardi P; Lenzi S; Rimondi S; Brunelli A; Casarini P; Bargossi A; Ceredi C; Dejana E
    Folia Endocrinol; 1972 Jun; 25(3):219-29. PubMed ID: 4677770
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Cardiol; 1986 Nov; 58(10):1035-40. PubMed ID: 3535471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure.
    Han Y; Fu L; Sun W; Cao J; Xie R; Zhou P; Kang N; Sun J
    Eur J Pharmacol; 2009 Oct; 619(1-3):68-74. PubMed ID: 19665014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sympatho-adrenergic function in congestive heart failure. I. Changes in urinary excretion of adrenaline and noradrenaline].
    Descovich GC; Bernardi P; Lenzi S; Rimondi S; Brunelli A; Casarini P; Bargossi A; Ceredi C; Montaguti U; Dejana E
    Boll Soc Ital Cardiol; 1972; 17(10):886-902. PubMed ID: 4681411
    [No Abstract]   [Full Text] [Related]  

  • 16. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma calcitonin gene-related peptide decreases in chronic congestive heart failure.
    Taquet H; Komajda M; Grenier O; Belas F; Landault C; Carayon A; Lechat P; Grosgogeat Y; Legrand JC
    Eur Heart J; 1992 Nov; 13(11):1473-6. PubMed ID: 1464337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.
    Goldstein DS
    Am J Cardiol; 1981 Dec; 48(6):1147-54. PubMed ID: 6171157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic nervous system in heart failure.
    Esler M; Kaye D; Lambert G; Esler D; Jennings G
    Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.